Renaissance Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-3,917
| Closed | -$453K | – | 279 |
|
|
2023
Q3 | $453K | Sell |
3,917
-1,226
| -24% | -$132K | 0.02% | 224 |
|
|
2023
Q2 | $529K | Sell |
5,143
-253,772
| -98% | -$26.8M | 0.02% | 222 |
|
|
2023
Q1 | $28.3M | Sell |
258,915
-27,725
| -10% | -$3.06M | 1.3% | 38 |
|
|
2022
Q4 | $32.6M | Sell |
286,640
-130,769
| -31% | -$10.9M | 1.6% | 3 |
|
|
2022
Q3 | $25.8M | Buy |
417,409
+118,902
| +40% | +$8.31M | 1.39% | 23 |
|
|
2022
Q2 | $23.8M | Sell |
298,507
-1,178
| -0.4% | -$112K | 1.23% | 42 |
|
|
2022
Q1 | $31.5M | Sell |
299,685
-2,088
| -0.7% | -$203K | 1.42% | 18 |
|
|
2021
Q4 | $32.5M | Sell |
301,773
-10,740
| -3% | -$1.17M | 1.32% | 31 |
|
|
2021
Q3 | $34.2M | Sell |
312,513
-2,759
| -0.9% | -$286K | 1.48% | 8 |
|
|
2021
Q2 | $29.5M | Sell |
315,272
-74,961
| -19% | -$6.9M | 1.24% | 35 |
|
|
2021
Q1 | $35.9M | Sell |
390,233
-15,150
| -4% | -$1.28M | 1.52% | 3 |
|
|
2020
Q4 | $29.7M | Sell |
405,383
-65,686
| -14% | -$4.88M | 1.27% | 24 |
|
|
2020
Q3 | $36.6M | Sell |
471,069
-47,284
| -9% | -$3.25M | 1.69% | 3 |
|
|
2020
Q2 | $28.8M | Buy |
518,353
+437,270
| +539% | +$18.7M | 1.37% | 11 |
|
|
2020
Q1 | $2.4M | Buy |
+81,083
| New | +$2.74M | 0.13% | 109 |
|
|
2017
Q1 | – | Sell |
-16,253
| Closed | -$263K | – | 313 |
|
|
2016
Q4 | $263K | Buy |
+16,253
| New | +$295K | 0.01% | 258 |
|
Other funds holding HZNP
IA
BTI
VWA
FSWA
BCMLT
HNB